Disease | insulinoma |
Symptom | C0020598|hypoglycemia |
Sentences | 19 |
PubMedID- 26113980 | Everolimus proved to be a viable treatment for hypoglycemia in insulinoma patients and was also proven highly effective in the patients presented here. |
PubMedID- 25844345 | A diagnosis of insulinoma was suspected in patients with symptomatic fasting hypoglycemia, which includes: (1) symptoms and signs of hypoglycemia, (2) concomitant plasma glucose level of ≤45 mg/dl, and (3) reversibility of symptoms with glucose administration. |
PubMedID- 23738155 | A case of inoperable malignant insulinoma with resistant hypoglycemia who experienced the most significant clinical improvement with everolimus. |
PubMedID- 25892896 | Here we report the case of a 79-year-old female who presented with repeated episodes of hypoglycemia and was diagnosed with insulinoma based on laboratory and imaging examinations. |
PubMedID- 25381469 | Although insulinomas typically present with fasting hypoglycemia, it is important to consider insulinoma in the differential diagnosis of patients presenting exclusively with postprandial hypoglycemia. |
PubMedID- 24130355 | Further support for this concept derives from recovery of iah and defective counterregulation after eliminating recurrent hypoglycemia in people with insulinoma (13,14) and in people with t1d after pancreas (15,16) and islet cell transplantation (17), as well as through adherence to treatment protocols aimed at meticulous prevention of hypoglycemia (18–21). |
PubMedID- 20930440 | Glucose-responsive insulinoma in a patient with postprandial hypoglycemia in the morning. |
PubMedID- 22844555 | insulinoma often presents with symptoms of hypoglycemia caused by an elevation of insulin levels in the blood. |
PubMedID- 22525212 | To our knowledge, this is the first report to provide evidence that strontium-89 can be useful in controlling intractable hypoglycemia in patients with malignant insulinoma with bone metastases. |
PubMedID- 21247848 | Conclusion: the orally administered drug everolimus controlled hypoglycemia due to a malignant insulinoma in a patient with prior insulin-requiring diabetes. |
PubMedID- 24358830 | Furthermore hypoglycemia due to an insulinoma especially in a young age group comes little lower in the list of other possible causes. |
PubMedID- 24396652 | The main causes of hypoglycemia combined with hyperinsulinemia are insulinoma, inappropriate use of antidiabetic agents, and autoimmune hypoglycemia. |
PubMedID- 26107678 | However, we believe that hypoglycemia in insulinoma patients is unlikely to produce rbd arising from rem sleep. |
PubMedID- 23392213 | Background: refractory hypoglycemia in patients with metastatic insulinoma is an important cause of morbidity and mortality. |
PubMedID- 21826148 | Taken together, these results suggested that inappropriate endogenous hyperinsulinemia was responsible for her hypoglycemia, possibly due to insulinoma, nesidioblastosis, or β cell dysfunction. |
PubMedID- 26425596 | Attenuated counterregulatory hormonal responses to severe hypoglycemia occur in patients with insulinoma,7-11 in infants with phhi,12,13 and in diabetic patients treated with excess exogenous insulin.14,15 insulinoma resection mitigates hyperinsulinemic hypoglycemic episodes and is associated with restoration of physiologic counterregulatory hormone response to hypoglycemia.7-11 we report 3 individuals who underwent rygb complicated by niphs and subsequently developed adrenal insufficiency (ai). |
PubMedID- 23237225 | Once hypoglycemia symptoms due to a suspected insulinoma are confirmed, the tumor should be localized prior to attempts at surgical resection. |
PubMedID- 25667631 | In the case that a patient presents with fasting hypoglycemia, the possibility of an insulinoma should be always considered. |
PubMedID- 20052354 | Regarding the endocrine function, 6 patients had diabetes mellitus and 2 patients had insulinoma with hypoglycemia preoperatively in organ-preserving pancreatectomy group. |
Page: 1